DK1125940T3 - Derivater af aryl- eller heteroaryl-quinolinylphosphonsyrer, fremgangsmåde til fremstilling heraf og farmaceutiske lægemidler som indeholder disse - Google Patents

Derivater af aryl- eller heteroaryl-quinolinylphosphonsyrer, fremgangsmåde til fremstilling heraf og farmaceutiske lægemidler som indeholder disse

Info

Publication number
DK1125940T3
DK1125940T3 DK01400407T DK01400407T DK1125940T3 DK 1125940 T3 DK1125940 T3 DK 1125940T3 DK 01400407 T DK01400407 T DK 01400407T DK 01400407 T DK01400407 T DK 01400407T DK 1125940 T3 DK1125940 T3 DK 1125940T3
Authority
DK
Denmark
Prior art keywords
quinolinylphosphonic
heteroaryl
aryl
derivatives
acids
Prior art date
Application number
DK01400407T
Other languages
English (en)
Inventor
Alex Cordi
Patrice Desos
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1125940T3 publication Critical patent/DK1125940T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK01400407T 2000-02-18 2001-02-16 Derivater af aryl- eller heteroaryl-quinolinylphosphonsyrer, fremgangsmåde til fremstilling heraf og farmaceutiske lægemidler som indeholder disse DK1125940T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002013A FR2805262A1 (fr) 2000-02-18 2000-02-18 Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1125940T3 true DK1125940T3 (da) 2003-05-05

Family

ID=8847124

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01400407T DK1125940T3 (da) 2000-02-18 2001-02-16 Derivater af aryl- eller heteroaryl-quinolinylphosphonsyrer, fremgangsmåde til fremstilling heraf og farmaceutiske lægemidler som indeholder disse

Country Status (23)

Country Link
US (1) US6420386B1 (da)
EP (1) EP1125940B1 (da)
JP (1) JP2001278890A (da)
KR (1) KR20010082704A (da)
CN (1) CN1317489A (da)
AR (1) AR027431A1 (da)
AT (1) ATE231154T1 (da)
AU (1) AU2303901A (da)
BR (1) BR0100600A (da)
CA (1) CA2337301A1 (da)
DE (1) DE60100080T2 (da)
DK (1) DK1125940T3 (da)
EA (1) EA200100157A3 (da)
ES (1) ES2190426T3 (da)
FR (1) FR2805262A1 (da)
HK (1) HK1039943A1 (da)
HU (1) HUP0100751A3 (da)
MX (1) MXPA01001559A (da)
NO (1) NO20010802L (da)
NZ (1) NZ510003A (da)
PL (1) PL345917A1 (da)
SI (1) SI1125940T1 (da)
ZA (1) ZA200101337B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805260A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2348018A4 (en) 2008-09-25 2012-04-25 Kyorin Seiyaku Kk HETEROCYCLIC BIARYLIC DERIVATIVE AND PDE INHIBITOR COMPRISING THE SAME AS ACTIVE INGREDIENT
WO2010041711A1 (ja) 2008-10-09 2010-04-15 杏林製薬株式会社 イソキノリン誘導体及びそれらを有効成分とするpde阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683818B1 (fr) * 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5342946A (en) * 1992-12-02 1994-08-30 Guilford Pharmaceuticals Inc. Phosphonoalkylquinolin-2-ones as novel antagonists of non-NMDA ionotropic excitatory amino acid receptors
FR2709489B1 (fr) * 1993-08-31 1995-10-20 Adir Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2750988B1 (fr) * 1996-07-11 1998-09-18 Adir Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0100751A3 (en) 2002-09-30
HUP0100751A2 (hu) 2002-01-28
PL345917A1 (en) 2001-08-27
EP1125940B1 (fr) 2003-01-15
HU0100751D0 (en) 2001-04-28
BR0100600A (pt) 2001-09-18
EA200100157A2 (ru) 2001-08-27
NZ510003A (en) 2001-09-28
AR027431A1 (es) 2003-03-26
SI1125940T1 (en) 2003-04-30
CN1317489A (zh) 2001-10-17
ATE231154T1 (de) 2003-02-15
AU2303901A (en) 2001-08-23
CA2337301A1 (fr) 2001-08-18
NO20010802L (no) 2001-08-20
ZA200101337B (en) 2001-08-21
KR20010082704A (ko) 2001-08-30
DE60100080D1 (de) 2003-02-20
NO20010802D0 (no) 2001-02-16
ES2190426T3 (es) 2003-08-01
EA200100157A3 (ru) 2001-10-22
MXPA01001559A (es) 2002-08-06
EP1125940A1 (fr) 2001-08-22
FR2805262A1 (fr) 2001-08-24
HK1039943A1 (zh) 2002-05-17
JP2001278890A (ja) 2001-10-10
US6420386B1 (en) 2002-07-16
DE60100080T2 (de) 2003-11-20

Similar Documents

Publication Publication Date Title
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20035220D0 (no) Karboksamidsubstituerte fenylureaderivater og fremgangsmåter for fremstilling av disse som legemidler
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
DK1117645T3 (da) Arylsubstituerede propanolaminderivater, fremgangsmåder til fremstilling deraf, lægemidler indeholdende disse forbindelser og anvendelse deraf
DK1169313T3 (da) Derivater af 1,4-benzothiazepin-1,1-dioxid substitueret med sukkerradikaler, fremgangsmåder til deres fremstilling, lægemidler som indeholder disse forbindelser og deres anvendelse
NO20032726D0 (no) Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
NO20042565L (no) Orale farmasoytiske produkter inneholdende 17 beta-ostradiol-3-lavere alkanoat, fremgangsmater for administrering av disse og fremgangsmater for fremstilling derav
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
NO994620D0 (no) Nye 2-(iminometyl)amino-fenyl-derivater, fremstilling, anvendelse som medisiner og farmasöytiske blandinger inneholdende disse
NO985262D0 (no) Fosfonsyresubstituerte benzazepinon-N-edikksyrederivater, fremgangsmÕte for deres fremstilling og legemidler inneholdende slike
DK1294689T3 (da) Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
NO20015659D0 (no) Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
DK1117661T3 (da) Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse
DK1558612T3 (da) Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1122254T3 (da) 4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
NO20016404D0 (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1171444T3 (da) Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK1275647T3 (da) Octahydro-1H-pyrido[1,2-a]pyrazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1165528T3 (da) Hidtil ukendte morpholinoderivater, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK1125940T3 (da) Derivater af aryl- eller heteroaryl-quinolinylphosphonsyrer, fremgangsmåde til fremstilling heraf og farmaceutiske lægemidler som indeholder disse